EE04094B1 - N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks - Google Patents

N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks

Info

Publication number
EE04094B1
EE04094B1 EEP199900279A EEP9900279A EE04094B1 EE 04094 B1 EE04094 B1 EE 04094B1 EE P199900279 A EEP199900279 A EE P199900279A EE P9900279 A EEP9900279 A EE P9900279A EE 04094 B1 EE04094 B1 EE 04094B1
Authority
EE
Estonia
Prior art keywords
irds
cyclopropylmethoxy
ards
treatment
difluoromethoxy
Prior art date
Application number
EEP199900279A
Other languages
English (en)
Estonian (et)
Inventor
Germann Paul-Georg
Kilian Ulrich
Beume Rolf
Amschler Hermann
Kr�ger Uwe
H�fner Dietrich
Eistetter Klaus
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE9900279A publication Critical patent/EE9900279A/xx
Publication of EE04094B1 publication Critical patent/EE04094B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP199900279A 1997-02-17 1998-02-14 N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks EE04094B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19
PCT/EP1998/000847 WO1998035683A1 (en) 1997-02-17 1998-02-14 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant

Publications (2)

Publication Number Publication Date
EE9900279A EE9900279A (et) 2000-02-15
EE04094B1 true EE04094B1 (et) 2003-08-15

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900279A EE04094B1 (et) 1997-02-17 1998-02-14 N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks

Country Status (25)

Country Link
US (2) US6436970B1 (OSRAM)
EP (1) EP0977577B1 (OSRAM)
JP (1) JP4763104B2 (OSRAM)
KR (1) KR100640025B1 (OSRAM)
CN (1) CN1123345C (OSRAM)
AT (1) ATE336254T1 (OSRAM)
AU (1) AU734122B2 (OSRAM)
BR (1) BR9807399B1 (OSRAM)
CA (1) CA2276429C (OSRAM)
CZ (1) CZ293871B6 (OSRAM)
DE (1) DE69835594T2 (OSRAM)
DK (1) DK0977577T3 (OSRAM)
EA (1) EA001758B1 (OSRAM)
EE (1) EE04094B1 (OSRAM)
ES (1) ES2271990T3 (OSRAM)
HU (1) HU227520B1 (OSRAM)
IL (1) IL130658A (OSRAM)
NO (1) NO323594B1 (OSRAM)
NZ (1) NZ336569A (OSRAM)
PL (1) PL190775B1 (OSRAM)
PT (1) PT977577E (OSRAM)
SI (1) SI0977577T1 (OSRAM)
TR (1) TR199901772T2 (OSRAM)
UA (1) UA50808C2 (OSRAM)
WO (1) WO1998035683A1 (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04094B1 (et) * 1997-02-17 2003-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks
JP2001081031A (ja) * 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
US7053176B1 (en) 1999-09-16 2006-05-30 Altana Pharma Ag Combination of C1-INH and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
CA2407780A1 (en) * 2000-05-25 2001-11-29 Merck Frosst Canada & Co./Merck Frosst Canada & Cie Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
JP4460221B2 (ja) 2001-05-24 2010-05-12 メルク フロスト カナダ リミテツド 1−ビアリール−1,8−ナフチリジン−4−オン系ホスホジエステラーゼ−4阻害薬
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
WO2004047828A1 (en) * 2002-11-27 2004-06-10 Altana Pharma Ag Synergistic combination compresing roflumilas and (r.r) -formoterol
JP2006508994A (ja) * 2002-11-27 2006-03-16 アルタナ ファルマ アクチエンゲゼルシャフト ロフルミラスト及びホルモテロールを含有する新規の相乗組合せ
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
CA2529007C (en) * 2003-06-16 2012-03-27 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
DE602005019416D1 (de) 2004-08-06 2010-04-01 Nycomed Gmbh Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
EP2258350B1 (en) * 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
BRPI0720032A2 (pt) * 2006-12-13 2013-12-17 Gilead Sciences Inc Composto e sais farmaceuticamente aceitáveis dos mesmos, processo, formulação de aerossol, método para a prevenção e tratamento de inflamação pulmonar ou broncoconstrição, e, uso de um composto.
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
EP3027738B1 (en) * 2013-08-01 2022-03-02 Swedish StromaBio AB Mscs in the treatment of inflammatory pulmonary diseases
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
PT78566B (de) * 1983-05-11 1986-07-17 Byk Gulden Lomberg Chem Fab Pyridazinone ihre herstellung und verwendung pyridazinone enthaltende arzneimittel
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
RU2137754C1 (ru) * 1993-07-02 1999-09-20 Бик Гульден Ломберг Хемише Фабрик ГмбХ Фторалкоксизамещенные бензамиды, способ их получения и фармацевтическая композиция на их основе
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
EE04094B1 (et) * 1997-02-17 2003-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
KR20020048911A (ko) * 1999-06-29 2002-06-24 엘-테크 코포레이션 화학 필름의 세정 및 건조 방법과 그 장치

Also Published As

Publication number Publication date
EP0977577A1 (en) 2000-02-09
US6436970B1 (en) 2002-08-20
CA2276429C (en) 2007-06-19
IL130658A (en) 2004-07-25
KR20000071112A (ko) 2000-11-25
AU734122B2 (en) 2001-06-07
HUP0001043A3 (en) 2002-12-28
NZ336569A (en) 2001-04-27
HK1026145A1 (en) 2000-12-08
HU227520B1 (hu) 2011-07-28
JP2001512452A (ja) 2001-08-21
KR100640025B1 (ko) 2006-10-31
DE69835594T2 (de) 2007-08-16
IL130658A0 (en) 2000-06-01
DE69835594D1 (de) 2006-09-28
US6998410B2 (en) 2006-02-14
DK0977577T3 (da) 2006-12-18
EE9900279A (et) 2000-02-15
EA001758B1 (ru) 2001-08-27
AU6497398A (en) 1998-09-08
HUP0001043A2 (hu) 2000-09-28
CZ291499A3 (cs) 2000-02-16
CZ293871B6 (cs) 2004-08-18
NO993875L (no) 1999-08-11
NO993875D0 (no) 1999-08-11
EA199900645A1 (ru) 2000-04-24
CN1123345C (zh) 2003-10-08
PL190775B1 (pl) 2006-01-31
JP4763104B2 (ja) 2011-08-31
CN1248169A (zh) 2000-03-22
US20020132835A1 (en) 2002-09-19
UA50808C2 (uk) 2002-11-15
ATE336254T1 (de) 2006-09-15
EP0977577B1 (en) 2006-08-16
WO1998035683A1 (en) 1998-08-20
PT977577E (pt) 2007-02-28
ES2271990T3 (es) 2007-04-16
PL335134A1 (en) 2000-04-10
CA2276429A1 (en) 1998-08-20
BR9807399A (pt) 2000-03-14
TR199901772T2 (OSRAM) 1999-09-21
BR9807399B1 (pt) 2011-04-19
SI0977577T1 (sl) 2007-02-28
NO323594B1 (no) 2007-06-11

Similar Documents

Publication Publication Date Title
EE04094B1 (et) N-(3,5-dikloro-4-püridinüül)-3-tsüklopropüülmetoksü-4-(difluorometoksü)bensamiidi ja kopsusurfaktanti sisaldavad kompositsioonid ARDS'i või IRDS'i ravimiseks
DK1282438T3 (da) Farmaceutisk sammensætning omfattende en faktor VIIa og en faktor XIII
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
ES2081716T3 (es) Procedimiento para la fabricacion de resina de organopolisiloxano.
DK0705099T3 (da) Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse
DK0494405T3 (da) Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
FI842588A7 (fi) Suun, nenän ja/tai nielun limakalvoihin vaikuttavat lääkeaineet, joiden perustana ovat hepariini ja tensidit.
ATE169225T1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
ID28119A (id) Pati yang dimodifikasi stabil-garam
DE69332654D1 (de) Fragmente eines oberflächenaktiven lungenproteins
BR9916489A (pt) Agente aromatizante tipo jogo
ES2176330T3 (es) Compuestos y composiciones para administracion por inhalacion oral o insuflacion.
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
RU97107034A (ru) Способ лечения синдрома сухого глаза
SE8903764D0 (sv) Lung protection agents
ES2188189T3 (es) Composiciones que comprenden derivados de acido fenil-amino-tiofeno-acetico para el tratamiento del sindrome de angustia respiratoria aguda o de adultos (ards) y del sindrome de angustia respiratoria de niños (irds).
ES2094837T3 (es) Metodo para inhibir la toxicidad pulmonar por oxigeno.
EE05184B1 (et) Kaloporosiidi derivaadid, nende valmistamine ja kasutamine ravimina, neid sisaldavad ravimid ning mikroorganismi Gloeoporus dichrous (Fr.:Fr.) tvi ST001714 (DSM 13784)
ATE235238T1 (de) Verwendung von 2,3- alkylcaebonyloxybenzoesäure zur behandlung des atemunwohlseinsydroms bei erwachsenen
ATE322541T1 (de) Pestivirus mutanten und dessen enthaltende impfstoffe
DK0458536T3 (da) Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner